University of Wisconsin–Madison

Tag: Alzheimer’s disease

Scientists produce human norepinephrine neurons from stem cells, with significant implications for researching diseases like Alzheimer’s and Parkinson’s

Researchers a have identified a protein key to the development of a type of brain cell believed to play a role in disorders like Alzheimer’s and Parkinson’s diseases and used the discovery to grow the neurons from stem cells for the first time.

Understanding the connection between Down syndrome and Alzheimer’s disease

Allison and Amber Westemeier get excited every time they take a trip to the Waisman Center from Oshkosh, WI.

Brad Christian, PhD – Slide of the Week

The extent to which amyloid-β burden and neurofibrillary tau tangle burden are associated with synaptic degeneration in vivo is not well known.

Barbara B. Bendlin, PhD – Slide of the Week

White matter (WM) degeneration is a critical component of early Alzheimer's disease (AD) pathophysiology.

Weight loss may be early predictor of Alzheimer’s disease in Down syndrome

Unintentional weight loss in people with Down syndrome may predict the onset of Alzheimer’s disease long before typical cognitive symptoms like memory loss and dementia are apparent.

Thoughts of gratitude: The Dewey family is a catalyst of support for the Waisman Center

Individuals with Down syndrome are at higher risk of developing Alzheimer’s disease, and it typically presents it at an earlier age than the general population. It is estimated that 90% of people with Down syndrome will have developed Alzheimer’s by age 65.

Sigan Hartley, PhD – Slide of the Week

People with Down Syndrome (DS) are at high risk for Alzheimer’s disease (AD) because of their unique biology and provide an unparalleled opportunity to develop biomarkers of preclinical AD.

Barbara Bendlin, PhD – Slide of the Week

Insulin resistance (IR) has been related to reduced cerebral glucose metabolism in regions identified as hypometabolic in Alzheimer’s clinical syndrome. Insulin secretion (IS) has been less studied than IR despite findings that decreased IS is an early indicator of future type 2 diabetes and a potential predictor of Alzheimer’s clinical syndrome.

Jose Martinez connects science and policy as a BTP trainee

While working as a health care administrator in Santa Cruz, California during the 2015 Zika virus outbreak, Jose Martinez realized his background in chemistry and pharmacology could be harnessed to set policies that are grounded in science.

Studying the connection between Alzheimer’s and Down syndrome for Down syndrome awareness month

By Emily Leclerc, Waisman Science Writer The month of October is Down Syndrome Awareness Month and is dedicated to not only raising awareness about Down syndrome but also to celebrating the abilities and accomplishments of those with Down syndrome. While people with Down syndrome often live long and fruitful lives, the condition does come with …